Risteys ·

Coding

Definition

OMOP Concept ID: 3026657— open in OHDSI Athena.
Part of collection: Rickettsia conorii Ab with 0 other OMOP concept — open in OHDSI Athena.

OMOP mapping QC

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution	Test outcome NA N A AA L LL H HH
3026657	s-ricoab	— (—)	85	90	100.00%	Distribution not available

Cohort

Number of people: 89 (50.56% female)

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

No data available for the duration from to last measurement distribution.

Statistics

People with ≥2 records: 7.87%
Median number of measurements per person: 1.0
Median duration from first to last measurement: 0.04 years

Number of measurements over the years

No data available for the distribution of number of measurements over the years.

Number of measurements per person

Distribution of lab values

No data available for the lab value distribution.

Reference range

N people

N records

—

<256/Kaikki

<256

<40/KAIKKI

Value range per person

No data available for the distribution of value range per person.

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Oral corticosteroids

2.93

5.24

1.0

1.1

—

371.20

—

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

2.82

4.92

1.0

1.1

—

320.00

—

ILD medications: prednisolone, methylprednisolone, prednisone

2.61

3.97

1.0

1.1

—

371.20

—

Inflammatory bowel disease treatment related agents

2.48

3.74

1.0

1.1

—

371.20

—

ILD medications

2.45

3.64

1.0

1.1

—

320.00

—

Abnormal findings on examination of blood, without diagnosis

3.74

3.33

1.0

1.1

—

371.20

—

First line medication for Crohn's disease

2.35

3.23

1.0

1.1

—

320.00

—

ILD medications: immunosuppressive drugs

2.77

3.17

1.1

—

371.20

—

Certain disorders involving the immune mechanism

5.00

3.05

1.0

1.1

—

371.20

—

L04AX Other immunosuppressants

2.89

3.01

1.1

—

371.20

—

Second line medication for Crohn's disease

2.55

2.43

1.1

—

371.20

—

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

2.13

2.26

1.1

—

371.20

—

Obesity, other/unspecified

3.10

2.22

1.0

1.1

—

371.20

—

Other and unspecified dermatitis

2.68

2.20

1.1

—

371.20

—

Pain in joint

2.54

2.02

1.0

1.1

—

371.20

—

Other disorders of lacrimal gland

3.08

2.01

1.1

—

371.20

—

Focal epilepsy, strict definition

3.75

1.93

1.0

1.1

—

371.20

—

Asthma-related pneumonia

2.95

1.92

1.0

1.1

—

371.20

—

Asthma, hospital admissions 3, pneumonia

2.95

1.92

1.0

1.1

—

371.20

—

Asthma-related pneumonia or sepsis

2.95

1.92

1.0

1.1

—

371.20

—

Other specific joint derangements/joint disorders

2.17

1.86

1.0

1.1

—

358.40

—

Other and unspecified effects of external causes

2.86

1.86

1.0

1.1

—

371.20

—

Other joint disorders

2.06

1.79

1.1

—

358.40

—

Dermatitis

2.26

1.78

1.2

1.1

—

371.20

—

Focal epilepsy

3.33

1.74

1.0

1.1

—

371.20

—

Explicit Sepsis

2.51

1.59

1.0

1.1

—

371.20

—

Liquid cancers

2.99

1.56

1.0

1.1

—

371.20

—

Disorders of lacrimal system

2.46

1.56

1.1

—

371.20

—

Disorders of vestibular function (Vertigo)

2.43

1.54

1.0

1.1

—

371.20

—

Diseases of inner ear

2.39

1.46

1.0

1.1

—

371.20

—

Asthma-related infections

2.05

1.45

1.0

1.1

—

320.00

—

Asthma, hospital admission 2, infections

2.05

1.45

1.0

1.1

—

320.00

—

Stomatitis and related lesions

3.13

1.44

1.0

1.1

—

371.20

—

Coagulation defects, purpura and other haemorrhagic conditions

3.13

1.44

1.0

1.1

—

371.20

—

Other bacterial intestinal infections, including avohilmo

2.73

1.43

1.2

1.1

—

371.20

—

Liquid cancers, including Hilmo

2.64

1.36

1.0

1.1

—

371.20

—

All chronic kidney diseases

2.17

1.34

1.0

1.1

—

371.20

—

Disorders of eyelid, lacrimal system and orbit

1.90

1.33

1.1

1.0

—

371.20

—

Explicit Sepsis, including avohilmo

2.42

1.31

1.0

1.1

—

371.20

—

L04AA Selective immunosuppressants

2.78

1.28

1.0

1.1

—

371.20

—

Primary_lymphoid and hematopoietic malignant neoplasms

2.78

1.28

1.0

1.1

—

371.20

—

2.03

1.25

1.0

1.1

—

320.00

—

Psoriasis

2.40

1.24

1.0

1.1

—

371.20

—

Intestinal infectious diseases, including avohilmo, including avohilmo

1.73

1.23

1.1

—

371.20

—

Subjective visual disturbances

2.63

1.21

1.0

1.1

—

371.20

—

Symptoms and signs involving speech and voice

2.31

1.18

1.0

1.1

—

371.20

—

Aplastic and other anaemias

2.29

1.11

1.0

1.1

—

371.20

—

Other nutritional deficiencies

1.83

1.08

1.0

1.1

—

371.20

—

Venous thromboembolism

2.17

1.07

1.0

1.1

—

371.20

—

Use of hypnotics and sedatives

1.69

1.05

1.0

1.1

—

371.20

—

Obesity related asthma

2.06

1.02

1.0

1.1

—

371.20

—

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

1.91

1.01

1.1

1.0

—

371.20

—

Papulosquamous disorders

2.00

1.00

1.0

1.1

—

371.20

—

Other and unspecified anaemias

2.09

0.89

1.0

1.1

—

371.20

—

Other anaemias

2.08

0.89

1.0

1.1

—

371.20

—

Unspecified haematuria

2.03

0.87

1.0

1.1

—

371.20

—

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

1.64

0.86

1.1

—

371.20

—

Codeine or tramadol medication

1.56

0.86

1.1

—

371.20

—

Dermatitis and eczema

1.52

0.80

1.1

—

371.20

—

Asthma (diagnoses ohter than nonallergic)

1.55

0.74

1.0

1.1

—

320.00

—

Mood [affective] disorders

1.51

0.73

1.1

—

371.20

—

Mood disorders

1.50

0.73

1.1

—

371.20

—

Persons encountering health services for other counselling and medical advice, not elsewhere classified

1.48

0.70

1.1

—

371.20

—

Type 2 diabetes, definitions combined, including avohilmo

0.53

0.69

1.0

1.1

—

371.20

—

Visual disturbances

1.63

0.66

1.0

1.1

—

371.20

—

Reimbursement for rheumatic diseases

1.58

0.64

1.0

1.1

—

371.20

—

Depression

1.47

0.64

1.1

—

371.20

—

Obesity

1.59

0.62

1.0

1.1

—

371.20

—

Obesity and other hyperalimentation

1.59

0.62

1.0

1.1

—

371.20

—

Acute tubulo-interstitial nephritis

1.53

0.59

1.0

1.1

—

320.00

—

Malignant neoplasm

1.53

0.59

1.0

1.1

—

371.20

—

Malignant neoplasm

1.53

0.59

1.0

1.1

—

371.20

—

Any event in cancer register

1.49

0.57

1.0

1.1

—

371.20

—

Symptoms and signs involving the urinary system

1.57

0.57

1.0

1.1

—

371.20

—

Disorders of sclera, cornea, iris and ciliary body

1.48

0.57

1.1

—

371.20

—

Pain (limb, back, neck, head abdominally)

1.50

0.55

1.0

1.1

—

371.20

—

Mouth breathing

1.58

0.54

1.0

1.1

—

371.20

—

Dyspnoea

1.47

0.52

1.0

1.1

—

371.20

—

Dizziness and giddiness

1.43

0.52

1.0

1.1

—

371.20

—

Excessive attrition of teeth

1.41

0.51

1.1

1.0

—

320.00

—

Symptoms and signs involving cognition, perception, emotional state and behaviour

1.40

0.48

1.0

1.1

—

320.00

—

Diseases of arteries, arterioles and capillaries

1.51

0.48

1.0

1.1

—

371.20

—

Abdominal and pelvic pain

1.41

0.47

1.0

1.1

—

371.20

—

Visual disturbances and blindness

1.49

0.47

1.0

1.1

—

371.20

—

Symptoms and signs involving the digestive system and abdomen

1.40

0.47

1.0

1.1

—

371.20

—

Bleeding

1.49

0.47

1.0

—

371.20

—

Any death

1.44

0.46

1.0

1.1

—

371.20

—

Dentofacial anomalies [including malocclusion]

0.58

0.46

1.0

1.1

—

371.20

—

All kidney diseases

1.38

0.46

1.0

1.1

—

320.00

—

Persons encountering health services in other circumstances, wide

1.35

0.44

1.1

—

371.20

—

Type 2 diabetes, strict (exclude DM1)

0.63

0.44

1.0

1.1

—

371.20

—

Type 2 diabetes, definitions combined

0.63

0.44

1.0

1.1

—

371.20

—

Other arrhythmias

1.42

0.42

1.0

1.1

—

371.20

—

Renal tubulo-interstitial diseases

1.41

0.41

1.0

1.1

—

320.00

—

Rotator cuff syndrome

1.38

0.41

1.0

1.1

—

371.20

—

Other symptoms and signs involving cognitive functions and awareness

1.53

0.41

1.0

1.1

—

371.20

—

Renal failure

1.52

0.41

1.0

1.1

—

371.20

—

Implicit bacterial Sepsis, including avohilmo

1.48

0.40

1.0

1.1

—

371.20

—

Triptan medication for migraine, min. 3 purchases

1.33

0.40

1.1

—

320.00

—

Other medical care

1.45

0.39

1.2

1.1

—

371.20

—

Bacterial Sepsis

1.42

0.39

1.0

1.1

—

371.20

—

Other chronic obstructive pulmonary disease, including avohilmo

1.41

0.39

1.0

1.1

—

371.20

—

Solid cancers

1.40

0.39

1.0

1.1

—

371.20

—

Injuries to the abdomen, lower back, lumbar spine and pelvis

1.41

0.38

1.2

1.1

—

371.20

—

Major coronary heart disease event

0.65

0.37

1.0

1.1

—

371.20

—

Other inflammation of eyelid, including avohilmo

1.43

0.35

1.0

1.1

—

320.00

—

Chronic lower respiratory diseases

1.28

0.35

1.0

1.1

—

320.00

—

Malignant neoplasm, including Hilmo

1.36

0.34

1.0

1.1

—

371.20

—

Obesity due to excess calories

1.33

0.33

1.0

1.1

—

371.20

—

Type 2 diabetes

0.69

0.31

1.0

1.1

—

371.20

—

Other anxiety disorders

1.32

0.31

1.0

1.2

—

371.20

—

Malignant neoplasm, wide definition

1.33

0.30

1.0

1.1

—

371.20

—

Disorders of lens

1.28

0.30

1.0

1.1

—

371.20

—

Cystitis

1.35

0.30

1.0

1.1

—

371.20

—

Other disorders of skin and subcutaneous tissue

1.23

0.29

1.0

1.1

—

371.20

—

Congenital malformations, deformations and chromosomal abnormalities, including avohilmo

1.32

0.28

1.1

—

320.00

—

Type 2 diabetes, wide definition

0.70

0.27

1.0

1.1

—

371.20

—

Bacterial pneumonia (organism specified)

1.33

0.23

1.0

1.1

—

371.20

—

Biguanides

0.75

0.23

1.0

1.1

—

371.20

—

Disorders of gallbladder, biliary tract and pancreas

0.74

0.23

1.0

1.1

—

371.20

—

Cough

1.30

0.23

1.0

1.1

—

371.20

—

Nonsuppurative otitis media, including avohilmo

1.27

0.22

1.0

1.1

—

320.00

—

Gingivitis and periodontal diseases

0.78

0.22

1.0

1.1

—

320.00

—

Fall on same level

1.20

0.22

1.1

—

320.00

—

Osteopathies and chondropathies

1.17

0.21

1.2

1.1

—

371.20

—

Solid cancers, including Hilmo

1.27

0.20

1.0

1.1

—

371.20

—

Diabetes, varying definitions

0.79

0.20

1.0

1.1

—

371.20

—

Diabetes mellitus

0.79

0.20

1.0

1.1

—

371.20

—

Disorders of synovium and tendon

1.18

0.19

1.0

1.1

—

371.20

—

Symptoms and signs involving the circulatory and respiratory systems

0.82

0.17

1.0

1.1

—

371.20

—

Appendectomy

1.14

0.16

1.1

—

371.20

—

Injuries to the elbow and forearm

0.74

0.15

1.2

1.1

—

320.00

—

Other heart diseases, wide

1.17

0.13

1.0

1.1

—

371.20

—

Neurotic, stress-related and somatoform disorders

1.16

0.13

1.0

1.1

—

371.20

—

Anxiety disorders

1.16

0.12

1.0

1.1

—

371.20

—

Other diseases of urinary system

1.16

0.11

1.0

1.1

—

371.20

—

Infections with a predominantly sexual mode of transmission, including avohilmo

1.09

0.09

1.4

1.1

—

320.00

—

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.04

0.09

1.2

1.1

—

371.20

—

Asthma, hospital admissions , main diagnosis only

1.14

0.08

1.0

1.1

—

320.00

—

Insulin medication

0.81

0.08

1.0

1.1

—

371.20

—

Acute appendicitis, no complications

1.07

0.08

1.0

1.1

—

371.20

—

Infections of the skin and subcutaneous tissue

1.06

0.08

1.1

—

371.20

—

Ischemic heart diseases

0.79

0.08

1.0

1.1

—

371.20

—

Diabetes medication

0.88

0.07

1.0

1.1

—

371.20

—

Diseases of middle ear and mastoid

1.02

0.07

1.0

1.1

—

320.00

—

Congenital malformations, deformations and chromosomal abnormalities

1.08

0.07

1.1

—

320.00

—

Other (not insulin) diabetes medications

0.84

0.07

1.0

1.1

—

371.20

—

Migraine, single triptan purchase ok & required. ICD-code if available is included

0.89

0.07

1.1

—

320.00

—

Triptan medication for migraine, single purchase ok

0.89

0.07

1.1

—

320.00

—

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

0.87

0.06

1.0

1.1

—

371.20

—

Caries of enamel

1.10

0.06

1.0

1.1

—

371.20

—

Diabetes, insulin treatment (Kela reimbursement)

0.94

0.00

1.0

1.1

—

371.20

—

Lower back pain or/and sciatica

1.04

0.00

1.0

1.1

—

320.00

—

Persons encountering health services for specific procedures and health care

0.96

0.00

1.1

—

320.00

—

Abnormalities of breathing

1.03

0.00

1.0

1.1

—

371.20

—

Asthma/COPD (KELA code 203)

0.95

0.00

1.0

1.1

—

320.00

—

Benzodiazepine use

1.04

0.00

1.0

1.1

—

371.20

—

Insulin, intermediate and long-acting

1.00

0.00

1.0

1.1

—

371.20

—

Diseases of appendix

0.88

0.00

1.0

1.1

—

371.20

—

Any reimbursement code in KELA

0.88

-0.00

1.0

1.1

—

358.40

—

Shoulder lesions

1.00

-0.00

1.0

1.1

—

371.20

—

Complications of medical and surgical care

0.88

-0.00

1.2

1.1

—

371.20

—

Appendicitis, broad definition

0.88

-0.00

1.0

1.1

—

371.20

—

All anxiety disorders

0.95

-0.00

1.0

1.1

—

371.20

—

Other obstructed labour

0.00

-0.00

0.0

1.0

—

Oxicams

0.00

-0.00

0.0

1.0

—

Missing teeth due to accident, extraction or parodontitis

1.01

-0.00

1.2

1.0

—

371.20

—

Fall on same level involving ice and snow

0.86

-0.00

1.0

1.1

—

371.20

—

Constipation

0.95

-0.00

1.3

1.1

—

371.20

—

Suppurative and unspecified otitis media

1.01

-0.00

1.0

1.1

—

320.00

—

Eustachian salpingitis and obstruction

0.00

-0.00

0.0

1.0

—

Care involving use of rehabilitation procedures

0.93

-0.00

1.0

1.1

—

371.20

—

Acute appendicitis

0.91

-0.00

1.0

1.1

—

371.20

—

Insulin, combination of fast acting with intermediate-acting or long-acting

0.91

-0.00

1.0

1.1

—

371.20

—

Diabetic neuropathy

0.00

-0.00

0.0

1.0

—

≡ Risteys

R14

FinnGen R13 + FinRegistry

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Rickettsia conorii Ab [Titer] in Serum

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS